SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Pharmos(PARS)
PARS 2.700+13.6%Jan 21 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: crysball who wrote (1040)7/18/1998 7:46:00 AM
From: Omer Shvili  Read Replies (1) of 1491
 
You can be sure that if PARS will raise money in the future, it will not come from the like of Castle Creek.
Currently, PARS has two approved drugs, one more entering phase III and HU211 in late phase II. At this stage, PARS will not need to raise money from hedge funds. If the company will raise additional funds (I hope and believe they won't), it will be done with a large investment bank.
Bob Cook (CFO) said that such private offerings are a thing of the past, and we won't see any more in the future.
I believe that PARS won't need to raise additional funds. A partner for HU211 will pay an up front fee, which will be sufficient. With the cash from such a deal, PARS will start posting positive cash flow before it runs out of cash.

Omer
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext